CH669385A5 - - Google Patents

Download PDF

Info

Publication number
CH669385A5
CH669385A5 CH2152/86A CH215286A CH669385A5 CH 669385 A5 CH669385 A5 CH 669385A5 CH 2152/86 A CH2152/86 A CH 2152/86A CH 215286 A CH215286 A CH 215286A CH 669385 A5 CH669385 A5 CH 669385A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
hydroxy
formula
group
propynyl
Prior art date
Application number
CH2152/86A
Other languages
German (de)
English (en)
Inventor
Franco Faustini
Alessio Roberto D
Vittoria Villa
Salle Enrico Di
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of CH669385A5 publication Critical patent/CH669385A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH2152/86A 1985-05-31 1986-05-28 CH669385A5 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513723A GB8513723D0 (en) 1985-05-31 1985-05-31 11-beta substituted steroids

Publications (1)

Publication Number Publication Date
CH669385A5 true CH669385A5 (sv) 1989-03-15

Family

ID=10579949

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2152/86A CH669385A5 (sv) 1985-05-31 1986-05-28

Country Status (21)

Country Link
JP (1) JPS6212796A (sv)
KR (1) KR860009035A (sv)
AU (1) AU587031B2 (sv)
BE (1) BE904846A (sv)
CH (1) CH669385A5 (sv)
DE (1) DE3617883A1 (sv)
DK (1) DK251386A (sv)
ES (1) ES8707972A1 (sv)
FI (1) FI862278A (sv)
FR (1) FR2582654B1 (sv)
GB (2) GB8513723D0 (sv)
GR (1) GR861405B (sv)
HU (1) HU197925B (sv)
IL (1) IL78957A (sv)
IT (1) IT1190014B (sv)
NL (1) NL8601387A (sv)
NZ (1) NZ216325A (sv)
PT (1) PT82665B (sv)
SE (1) SE8602449L (sv)
SU (1) SU1508963A3 (sv)
ZA (1) ZA864065B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289073B1 (en) * 1987-04-24 1991-11-27 Akzo N.V. Novel 11-aryloestrane and 11-arylpregnane derivatives
EP0321010B1 (en) * 1987-12-12 1993-02-03 Akzo N.V. New 11-arylsteroid compounds
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
DE19961219A1 (de) * 1999-12-15 2001-07-19 Jenapharm Gmbh 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488682A (de) * 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
FR205F (sv) * 1965-10-22
FR5913M (sv) * 1965-12-02 1968-04-01
NL128375C (sv) * 1966-02-18
FR2054527B1 (sv) * 1969-07-28 1973-06-08 Roussel Uclaf
FR2054525B1 (sv) * 1969-07-28 1973-01-12 Roussel Uclaf
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions

Also Published As

Publication number Publication date
ES555298A0 (es) 1987-09-01
AU587031B2 (en) 1989-08-03
SU1508963A3 (ru) 1989-09-15
BE904846A (fr) 1986-12-01
ZA864065B (en) 1987-01-28
PT82665B (pt) 1988-08-17
IT1190014B (it) 1988-02-10
FI862278A (fi) 1986-12-01
DE3617883A1 (de) 1986-12-04
IT8620598A1 (it) 1987-11-28
GR861405B (en) 1986-09-26
GB8513723D0 (en) 1985-07-03
GB2175905A (en) 1986-12-10
FI862278A0 (fi) 1986-05-29
NL8601387A (nl) 1986-12-16
FR2582654B1 (fr) 1988-06-03
KR860009035A (ko) 1986-12-19
PT82665A (en) 1986-06-01
JPS6212796A (ja) 1987-01-21
HUT44575A (en) 1988-03-28
SE8602449D0 (sv) 1986-05-29
ES8707972A1 (es) 1987-09-01
IL78957A (en) 1990-11-29
GB2175905B (en) 1989-01-18
FR2582654A1 (fr) 1986-12-05
IT8620598A0 (it) 1986-05-28
HU197925B (en) 1989-06-28
DK251386D0 (da) 1986-05-29
SE8602449L (sv) 1986-12-01
NZ216325A (en) 1989-01-27
GB8612866D0 (en) 1986-07-02
AU5806286A (en) 1986-12-04
DK251386A (da) 1986-12-01
IL78957A0 (en) 1986-09-30

Similar Documents

Publication Publication Date Title
EP0648778B1 (de) Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT396239B (de) Verfahren zur herstellung von neuen in 4-stellung substituierten androstendionderivaten
DD263532A5 (de) Verfahren zur herstellung von 11 beta-(4-isopropenylphenyl)-estra-4,9-dienen
EP0404283B1 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
DE3844408A1 (de) In 17 (alpha)-stellung substituierte, neue 17ss-oh-19-norsteroid-derivate, deren herstellungsverfahren, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
CH668599A5 (de) Substituierte androsta-1,4-dien-3,17-dione und verfahren zu deren herstellung.
WO2008151745A1 (de) 17beta-cyano-18a-homo-19-nor-androst-4-en-derivat, dessen verwendung und das derivat enthaltende arzneimittel
WO1988007051A1 (en) 19, 11beta-BRIDGED STEROIDS, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
DE4332284C2 (de) 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0277089A1 (de) 11 Beta-alkinyl-estrene und -estradiene, deren Herstellung und diese enthaltende pharmezeutische Präparate
EP1525215B1 (de) Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
EP2170925B1 (de) 17ß-CYANO-19-NOR-ANDROST-4-EN-DERIVAT, DESSEN VERWENDUNG UND DAS DERIVAT ENTHALTENDE ARZNEIMITTEL
DE3820948A1 (de) 10ss, 11ss-ueberbrueckte steroide
CH669385A5 (sv)
DE2107835A1 (de) Neues Pregnanderivat und Verfahren zu dessen Herstellung
EP1599493B1 (de) Antitumor wirksame 2-substituierte estra-1,3,5(10)-trien-3-yl sulfamate
DE4042004A1 (de) 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
DE2428679A1 (de) Steroidverbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen
DE4132182A1 (de) 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE1468311A1 (de) 6-Substituierte 3-Alkoxy-17 alpha-acyloxy-4,6-pregnadien-20-one sowie Verfahren zu ihrer Herstellung
DE3619413A1 (de) 9(alpha), 10(alpha)-methylen-estrene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4447401A1 (de) 14,17-C¶2¶-überbrückte Steroide
DE3644358A1 (de) 10(beta)-alkynyl-4,9(11)-oestradien-derivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
EP1339733B1 (de) Verfahren zur herstellung von 4-(17alpha-methyl-substituierten)3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e oder 1z)-oximen
DE3706647A1 (de) 3-desoxo-10ss-alkynylsteroide, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Legal Events

Date Code Title Description
PL Patent ceased